Avant Brands Inc. (AVNT.TO)
CAD 1.05
(8.25%)
CAD 1.05
(8.25%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 17.93 Million CAD | 577.75% |
| 2022 | -3.75 Million CAD | 72.59% |
| 2021 | -13.69 Million CAD | -299.27% |
| 2020 | 6.87 Million CAD | 32.14% |
| 2019 | 5.19 Million CAD | 11.69% |
| 2018 | 4.65 Million CAD | 3242.55% |
| 2017 | -148.12 Thousand CAD | -944.72% |
| 2016 | -14.17 Thousand CAD | 87.59% |
| 2015 | -114.2 Thousand CAD | -4002.12% |
| 2014 | -2784.00 CAD | 98.12% |
| 2013 | -148.36 Thousand CAD | -139.98% |
| 2012 | -61.82 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 13.18 Million CAD | -20.31% |
| 2024 Q3 | 4.93 Million CAD | 0.0% |
| 2024 Q1 | 16.54 Million CAD | -7.75% |
| 2023 FY | 17.93 Million CAD | 577.75% |
| 2023 Q2 | 14.5 Million CAD | 14.15% |
| 2023 Q3 | 17.63 Million CAD | 21.59% |
| 2023 Q1 | 12.7 Million CAD | 438.58% |
| 2023 Q4 | 17.93 Million CAD | 1.67% |
| 2022 Q1 | -11.11 Million CAD | 18.84% |
| 2022 FY | -3.75 Million CAD | 72.59% |
| 2022 Q4 | -3.75 Million CAD | 36.09% |
| 2022 Q3 | -5.87 Million CAD | 30.68% |
| 2022 Q2 | -8.47 Million CAD | 23.76% |
| 2021 Q1 | 4 Million CAD | -41.67% |
| 2021 FY | -13.69 Million CAD | -299.27% |
| 2021 Q4 | -13.69 Million CAD | 12.54% |
| 2021 Q3 | -15.65 Million CAD | 7.49% |
| 2021 Q2 | -16.91 Million CAD | -522.24% |
| 2020 Q2 | 6.96 Million CAD | 0.55% |
| 2020 FY | 6.87 Million CAD | 32.14% |
| 2020 Q4 | 6.87 Million CAD | 8.04% |
| 2020 Q3 | 6.35 Million CAD | -8.71% |
| 2020 Q1 | 6.92 Million CAD | 33.26% |
| 2019 Q2 | 4.38 Million CAD | 112.04% |
| 2019 Q3 | 6.37 Million CAD | 45.28% |
| 2019 FY | 5.19 Million CAD | 11.69% |
| 2019 Q1 | 2.06 Million CAD | -55.54% |
| 2019 Q4 | 5.19 Million CAD | -18.45% |
| 2018 Q1 | -142.72 Thousand CAD | 3.64% |
| 2018 FY | 4.65 Million CAD | 3242.55% |
| 2018 Q4 | 4.65 Million CAD | 1354.35% |
| 2018 Q3 | -371.08 Thousand CAD | -463.94% |
| 2018 Q2 | 101.96 Thousand CAD | 171.44% |
| 2017 Q2 | -338.85 Thousand CAD | -1388.76% |
| 2017 Q1 | -22.76 Thousand CAD | -60.54% |
| 2017 FY | -148.12 Thousand CAD | -944.72% |
| 2017 Q4 | -148.12 Thousand CAD | 24.88% |
| 2017 Q3 | -197.16 Thousand CAD | 41.81% |
| 2016 Q1 | -99.74 Thousand CAD | 12.66% |
| 2016 Q2 | -26.42 Thousand CAD | 73.51% |
| 2016 Q4 | -14.17 Thousand CAD | -5.95% |
| 2016 Q3 | -13.38 Thousand CAD | 49.35% |
| 2016 FY | -14.17 Thousand CAD | 87.59% |
| 2015 Q3 | -171.64 Thousand CAD | -8840.05% |
| 2015 FY | -114.2 Thousand CAD | -4002.12% |
| 2015 Q4 | -114.2 Thousand CAD | 33.47% |
| 2015 Q1 | -2738.00 CAD | 1.65% |
| 2015 Q2 | -1920.00 CAD | 29.88% |
| 2014 Q4 | -2784.00 CAD | 92.69% |
| 2014 FY | -2784.00 CAD | 98.12% |
| 2014 Q1 | -87.91 Thousand CAD | 40.74% |
| 2014 Q3 | -38.1 Thousand CAD | 58.23% |
| 2014 Q2 | -91.21 Thousand CAD | -3.75% |
| 2013 Q4 | -148.36 Thousand CAD | 44.08% |
| 2013 Q1 | -53.98 Thousand CAD | 0.0% |
| 2013 FY | -148.36 Thousand CAD | -139.98% |
| 2013 Q2 | -49.98 Thousand CAD | 7.41% |
| 2013 Q3 | -265.29 Thousand CAD | -430.74% |
| 2012 FY | -61.82 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | -8.64 Million CAD | 307.331% |
| Avicanna Inc. | 1.32 Million CAD | -1251.984% |
| Cardiol Therapeutics Inc. | -34.77 Million CAD | 151.563% |
| Crescita Therapeutics Inc. | -8.13 Million CAD | 320.514% |
| Knight Therapeutics Inc. | 10.33 Million CAD | -73.572% |
| MediPharm Labs Corp. | -15.68 Million CAD | 214.306% |
| OrganiGram Holdings Inc. | -33.7 Million CAD | 153.191% |
| Canopy Growth Corporation | 512.87 Million CAD | 96.504% |
| Willow Biosciences Inc. | -989 Thousand CAD | 1912.942% |
| Auxly Cannabis Group Inc. | 142.88 Million CAD | 87.451% |